These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11682992)

  • 21. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-HIV agents. Alternating regimens look promising.
    TreatmentUpdate; 2003; 15(5):2-3. PubMed ID: 17216855
    [No Abstract]   [Full Text] [Related]  

  • 23. Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks.
    Paton NI; Aboulhab J
    HIV Med; 2005 Jan; 6(1):13-20. PubMed ID: 15670247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-HIV agents. How long will a first regimen last?
    TreatmentUpdate; 2003; 15(5):1-2. PubMed ID: 17219614
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.
    Clevenbergh P; Boulmé R; Kirstetter M; Dellamonica P
    HIV Med; 2004 Jul; 5(4):284-8. PubMed ID: 15236618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2006 IAPAC state of HIV treatment surveys. Comprehensive insights into the mindsets of HIV-positive patients and HIV-treating physicians.
    IAPAC Mon; 2006 May; 12(5):150-5. PubMed ID: 17249141
    [No Abstract]   [Full Text] [Related]  

  • 27. Complications & side effects. Can statins be used as anti-HIV drugs?
    TreatmentUpdate; 2004; 16(7):9. PubMed ID: 17219689
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV therapeutics: points from the recent literature.
    Laurence J
    AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
    [No Abstract]   [Full Text] [Related]  

  • 29. Retrospective analysis of antiretroviral HIV treatment success based on medical history or guided by the reverse hybridisation LiPA HIV genotyping system.
    Alvarez M; García F; Martínez NM; Hernández Quero J; Louwagie J; De Brauwer A; Maroto MC
    J Med Virol; 2004 Jun; 73(2):151-7. PubMed ID: 15122786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Who gets treatment and...side effects.
    TreatmentUpdate; 2002 Dec; 14(9):2-3. PubMed ID: 12593382
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes in viral load in people with virological failure who remain on the same HAART regimen.
    Cozzi-Lepri A; Phillips AN; Miller V; Katlama C; Ledergerber B; Vella S; Weber J; Bruun JN; Kirk O; Clotet B; Lundgrens JD
    Antivir Ther; 2003 Apr; 8(2):127-36. PubMed ID: 12741625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy?
    Giordano TP; Wright JA; Hasan MQ; White AC; Graviss EA; Visnegarwala F
    Clin Infect Dis; 2003 Aug; 37(3):433-7. PubMed ID: 12884169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
    Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
    AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures.
    La Sala GB; Pilotti E; Nicoli A; Pinelli S; Villani MT; Ronzi P; Zendri E; Re MC; Magnani G; Casoli C
    AIDS; 2007 Jan; 21(3):377-9. PubMed ID: 17255749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
    HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors of treatment interruption duration in a cohort of HIV-1 infected patients with CD4 count greater than 350 cells per mm3.
    Fillaux J; Delpierre C; Alvarez M; Jaafar A; Marchou B; Massip P; Cuzin L
    Med Mal Infect; 2006 Jun; 36(6):335-9. PubMed ID: 16631330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection.
    Chantry CJ; Byrd RS; Englund JA; Baker CJ; McKinney RE;
    Pediatr Infect Dis J; 2003 Dec; 22(12):1033-9. PubMed ID: 14688560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral suppression of HIV in the context of persistently low CD4 counts: new insights.
    Laurence J
    AIDS Read; 2007 Jan; 17(1):7, 18. PubMed ID: 17274141
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
    Wolbers M; Battegay M; Hirschel B; Furrer H; Cavassini M; Hasse B; Vernazza PL; Bernasconi E; Kaufmann G; Bucher HC;
    Antivir Ther; 2007; 12(6):889-97. PubMed ID: 17926643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.